KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Humana (HUM) over the last 17 years, with Q3 2025 value amounting to $135.0 million.

  • Humana's Capital Expenditures rose 384.62% to $135.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $498.0 million, marking a year-over-year decrease of 2926.14%. This contributed to the annual value of $575.0 million for FY2024, which is 4272.91% down from last year.
  • As of Q3 2025, Humana's Capital Expenditures stood at $135.0 million, which was up 384.62% from $114.0 million recorded in Q2 2025.
  • Humana's Capital Expenditures' 5-year high stood at $397.0 million during Q4 2021, with a 5-year trough of $95.0 million in Q1 2025.
  • Over the past 5 years, Humana's median Capital Expenditures value was $264.0 million (recorded in 2023), while the average stood at $231.7 million.
  • Its Capital Expenditures has fluctuated over the past 5 years, first soared by 5104.17% in 2021, then tumbled by 5681.82% in 2024.
  • Quarter analysis of 5 years shows Humana's Capital Expenditures stood at $397.0 million in 2021, then crashed by 30.73% to $275.0 million in 2022, then increased by 2.91% to $283.0 million in 2023, then tumbled by 45.58% to $154.0 million in 2024, then fell by 12.34% to $135.0 million in 2025.
  • Its Capital Expenditures stands at $135.0 million for Q3 2025, versus $114.0 million for Q2 2025 and $95.0 million for Q1 2025.